Schedule 13D ownership disclosure

SECOND SIGHT MEDICAL PRODUCT

Security class unavailable · CUSIP: 81362J100

Event date: 2022-05-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
172,926,799
Percent of class
38.0600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-22-000957
Form type
SC 13D/A
Filer
Vivani Medical, Inc.
CIK
CIK 1266806
Filed
Jul 22, 2022
Reporting period
May 18, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub